Top Story

Omeros completes enrollment in pediatric clinical trial of Omidria

July 1, 2016

Omeros has completed patient enrollment in a post-marketing pediatric clinical trial of Omidria, according to a press release.

As an FDA post-marketing requirement, the company has enrolled 70 cataract surgery patients between 0 and 3 years of age. Upon successful completion of the clinical trial, Omeros will be eligible to receive an additional 6 months of marketing exclusivity for Omidria (phenylephrine 1% and ketorolac 0.3% injection).

FDA approves Humira for treatment of noninfectious intermediate, posterior and panuveitis

July 1, 2016
The FDA has approved Humira for the treatment of noninfectious intermediate and posterior uveitis and panuveitis, according to a press release from AbbVie. With this…
VideoFrom OSN Europe

VIDEO: GOA Glaucoma to take place in Genoa

July 1, 2016
PRAGUE — Carlo Enrico Traverso, MD, invites colleagues to join the GOA Glaucoma international course that will take place in Genoa, Italy, Mar. 31 to Apr. 1, 2017.

Cirurgiões reveem os novos tratamentos para o glaucoma

Ocular Surgery News Latin America Edition, July 2016
Bem-vindo a mais uma edição dos Debates CEDARS/ASPENS. CEDARS/ASPENS é uma sociedade de especialistas em córnea, catarata e cirurgia refrativa, reunida aqui para…
Complications Consult

Posición correcta esencial para la técnica de ‘handshake’

Ocular Surgery News Latin America Edition, July 2016
Amar Agarwal, MS FRCS FRCOphth; Priya Narang, MS
Es esencial la posición adecuada del cirujano y el ojo del paciente; el objetivo en la selección y ajuste de una posición de cirugía particular es mantener la facilidad…
More News Headlines »
Clinical Science

The Role of Anti-VEGF Therapy in the Treatment of Diabetic Macular Edema

Ophthalmic Surgery, Lasers and Imaging Retina, June 2016, Volume 47 Issue 6
Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults. DR often leads to diabetic…
More »

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Highlights from ASCRS

Highlights from ASCRS

From OSN Europe Video

VIDEO: Speaker presents interim results of phase 4 clinical trial of Xen gel stent

June 29, 2016
More »